Panacea Biotec Ltd (PNCA.NS)

PNCA.NS on National Stock Exchange of India

129.05INR
3 Jul 2015
Change (% chg)

Rs-2.80 (-2.12%)
Prev Close
Rs131.85
Open
Rs132.10
Day's High
Rs135.40
Day's Low
Rs128.00
Volume
20,111
Avg. Vol
81,074
52-wk High
Rs219.35
52-wk Low
Rs99.10

PNCA.NS

Chart for PNCA.NS

About

Panacea Biotec Ltd is an India-based pharmaceutical company. The Company’s businesses include biologicals, pharmaceuticals formulation, research & development. Panacea Biotec has brand equity in branded pharmaceutical formulations including Oncology, Nephrology, Organ Transplant, Pain Management, and Diabetes Management. The... (more)
No analyst recommendations are available for PNCA.NS.

Overall

Beta: 0.77
Market Cap(Mil.): Rs7,778.85
Shares Outstanding(Mil.): 61.25
Dividend: --
Yield (%): --

Financials

  PNCA.NS Industry Sector
P/E (TTM): -- 35.34 39.54
EPS (TTM): -- -- --
ROI: -- 17.03 16.22
ROE: -- 17.94 17.36
Search Stocks

BRIEF-Demire purchases interests in management companies

May 27 - Demire Deutsche Mittelstand Real Estate AG : * Acquired a 51 percent interest in asset management company Panacea Property GmbH * Says also acquired 51 percent interest in facility management company Praedia Haus & Gartenservice GmbH * Says the parties to the transaction have agreed not to disclose the purchase

27 May 2015

Earnings vs. Estimates

Search Stocks